Thomas Hesterkamp
Braunschweig, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.
Journal: Cell host & microbe
Published: August 23, 2024
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters.
Journal: ACS pharmacology & translational science
Published: July 18, 2024
Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models.
Journal: Microbiology spectrum
Published: December 04, 2023
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
Journal: NPJ vaccines
Published: July 27, 2023
Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A.
Journal: mSphere
Published: September 12, 2022
In Vitro-In Vivo Relationship in Mini-Scale-Enabling Formulations of Corallopyronin A.
Journal: Pharmaceutics
Published: July 12, 2022
Corallopyronin A: antimicrobial discovery to preclinical development.
Journal: Natural product reports
Published: June 22, 2022
The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus.
Journal: Antibiotics (Basel, Switzerland)
Published: June 13, 2022
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
Journal: Nature communications
Published: February 12, 2022
Towards the sustainable discovery and development of new antibiotics.
Journal: Nature reviews. Chemistry
Published: July 01, 2021
Towards the sustainable discovery and development of new antibiotics.
Journal: Nature reviews. Chemistry
Published: July 01, 2021
Last Updated: 09/26/2026